Skip to main content
SpringerLink
Log in

Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma

  • Letter to the Editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Batista DL, Zhang X, Gejman R, Ansell PJ, Zhou Y, Johnson SA, Swearingen B, Hedley-Whyte ET, Stratakis CA, Klibanski A (2006) The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab 91:4482–4488

    Article  CAS  PubMed  Google Scholar 

  2. Hofland LJ, van der Hoek J, Feelders R, van Aken MO, van Koetsveld PM, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, de Herder WW, Beckers A, Lamberts SW (2005) The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. Eur J Endocrinol 152:645–654

    Article  CAS  PubMed  Google Scholar 

  3. Hofland LJ (2008) Somatostatin and somatostatin receptors in Cushing’s disease. Mol Cell Endocrinol 286:199–205

    Article  CAS  PubMed  Google Scholar 

  4. Ciric I (1985) Pituitary tumors. Neurol Clin 3:751–768

    CAS  PubMed  Google Scholar 

  5. Gierach M, Pufal J, Pilecki S, Junik R (2005) The case of Cushing’s disease imaging by SPECT examination without manifestation of pituitary adenoma in MRI examination. Nucl Med Rev Cent East Eur 8:137–139

    PubMed  Google Scholar 

  6. Watson JC, Shawker TH, Nieman LK, DeVroom HL, Doppman JL, Oldfield EH (1998) Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing’s disease and no demonstrable pituitary tumor on magnetic resonance imaging. J Neurosurg 89:927–932

    Article  CAS  PubMed  Google Scholar 

  7. Greenman Y, Melmed S (1994) Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab 78:398–403

    Article  CAS  PubMed  Google Scholar 

  8. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A (1995) Somatostatin receptor subtype gene expression in pituitary adenomas. J Clin Endocrinol Metab 80:1386–1392

    Article  CAS  PubMed  Google Scholar 

  9. Day R, Dong W, Panetta R, Kraicer J, Greenwood MT, Patel YC (1995) Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology 136:5232–5235

    Article  CAS  PubMed  Google Scholar 

  10. Nielsen S, Mellemkjaer S, Rasmussen LM, Ledet T, Olsen N, Bojsen-Moller M, Astrup J, Weeke J, Jorgensen JO (2001) Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo. J Endocrinol Invest 24:430–437

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank David M. Wildrick, Ph.D. and Sherita Daniel, B.S. (Research Histology Core Lab) for their valuable assistance.

Author information

Authors and Affiliations

  1. The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA

    Wael Hassaneen, Daniel P. Cahill, Gregory N. Fuller & Nicholas B. Levine

Authors
  1. Wael Hassaneen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel P. Cahill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gregory N. Fuller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicholas B. Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wael Hassaneen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hassaneen, W., Cahill, D.P., Fuller, G.N. et al. Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma. J Neurooncol 98, 151–152 (2010). https://doi.org/10.1007/s11060-009-0048-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-0048-5

Keywords

Search

Navigation